Global /United States /Healthcare /Biotechnology /BSEM
chevron_leftBack
BioStem Technologies, Inc. logo

BioStem Technologies, Inc.

BSEM
OTCMKTS: BSEM Delayed
4.52USD -4.2%
As of 13 June 2026, BioStem Technologies, Inc. has a market cap of $80.04M USD, ranking #27132 globally and #4121 in the United States. It ranks #2434 in the Healthcare sector, and #469 in the Biotechnology industry.
Global Rank
27132
Country Rank
4121
Sector Rank
2434
Industry Rank
469
Key Stats
Market Cap
$80.04MUSD
Enterprise Value
$53.83MUSD
Revenue (TTM)
$47.48MUSD
EBITDA (TTM)
-$459.35KUSD
Net Income (TTM)
-$6.58MUSD
EBITDA Margin
-1%
Profit Margin
-14%
PS Ratio
1.7
PB Ratio
2.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Matuszewski open_in_new
Employees
33
Founded
2006
Website
biostemtechnologies.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-4.2% -1.5% 3.3% -41% 1.6% -69%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
BSEM
BioStem Technologies Inc
ISIN: US0906842002
Shares Out.:
16.338M1 Shares Float: 11.493M2
TV:
SA:
YF:
GF:
BA:
MS:
4.52 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About BioStem Technologies, Inc.

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

Similar Companies

Industry: Biotechnology (United States)
Name
Market Cap diff.
PE
AMGN
$182.42B
228K%
23.9
GILD
$159.92B
200K%
19.0
NTRA
$27.6B
34K%
-
$26.3B
33K%
20.0
$25.03B
31K%
20.4
MRNA
$18.13B
23K%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
ARGX
$47.84B
41.39B EUR
60K%
39.9
$44.84B
68.19T KRW
56K%
35.5
CSL
$42.36B
60.27B AUD
53K%
29.3
LONN
$42.3B
33.71B CHF
53K%
37.2
068270
$28.11B
42.76T KRW
35K%
43.8
BNTX
$25.69B
32K%
-
chevron_leftBack